Eurlexa

English
- Sign in
- Register

Commission Regulation (EC) No 1000/98 of 13 May 1998 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)

Commission Regulation (EC) No 1000/98of 13 May 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Community,Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal originOJ L 224, 18. 8. 1990, p. 1., as last amended by Commission Regulation (EC) No 613/98OJ L 82, 19. 3. 1998, p. 14., and in particular Articles 6, 7 and 8 thereof,Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be established progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals;Whereas maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs;Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue);Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney, whereas, however, the liver and kidney are frequently removed from carcases moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues;Whereas, in the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey;Whereas thiabendazole, flubendazole, thiamphenicol, doxycycline and oxibendazole should be inserted into Annex I to Regulation (EEC) No 2377/90;Whereas sodium selenite, sodium selenate and potassium selenate should be inserted into Annex II to Regulation (EEC) No 2377/90;Whereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustment which may be necessary to the authorisations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/851 /EECOJ L 317, 6. 11. 1981, p. 1., as last amended by Directive 93/40/EECOJ L 214, 24. 8. 1993, p. 31., to take account of the provisions of this Regulation;Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,HAS ADOPTED THE FOLLOWING REGULATION:

Article 1Annexes I and II to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

Article 2This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 13 May 1998.For the CommissionMartin BangemannMember of the CommissionANNEXA.Annex I to Regulation (EEC) No 2377/90 is amended as follows:1.Anti-infectious agents1.2.Antibiotics1.2.6.Tetracyclines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
"Doxycycline	Doxycycline	Bovine	100 μg/kg	Muscle
			300 μg/kg	Liver
			600 μg/kg	Kidney
		Porcine, poultry	100 μg/kg	Muscle
			300 μg/kg	Skin and fat
			300 μg/kg	Liver
			600 μg/kg	Kidney"

1.2.7.Thiamphenicol and related compounds

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
"Thiamphenicol	Thiamphenicol	Bovine	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk
		Chicken:	Not for use in animals from which eggs are produced for human consumption	50 μg/kg
		Muscle	50 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney"

2.1.3.Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
"Flubendazole	Sum of flubendazole and (2-amino 1 H-benzimid-azol-5-yl) (4 flurorophenyl)methanone	Porcine, chicken, game birds	50 U£/kg	Skin and fat
			400 μg/kg	Liver
			300 μg/kg	Kidney
	Flubendazole	Chicken	400 μg/kg	Eggs
Oxibendazole	Oxibendazole	Porcine	100 μg/kg	Muscle
			500 μg/kg	Skin and fat
			200 μg /kg	Liver
			100 μg/kg	Kidney
Thiabendazole	Sum of thiabendazole and 5-hydroxythia-bendazole	Bovine	100 μg /kg	Muscle
			100 μg/kg	Fat
			100 μg/kg	Liver
			100 μg/kg	Kidney
			100 μg /kg	Milk"

B.Annex II to Regulation (EEC) No 2377/90 is amended as follows:1.Inorganic chemicals

Pharmacologically active substance(s)	Animal species	Other provisions
"Potassium selenate	All food producing species
Sodium selenate	All food producing species
Sodium selenete	All food producing species"